Akebia Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC AKBA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

319,797

Value ($000)

515

Weight

0.0%

2019 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	515	0.0%	319,797	12/31/2025
2025 Q3	11/14/2025	893	0.0%	326,959	9/30/2025
2025 Q2	8/14/2025	99	0.0%	27,305	6/30/2025
2022 Q1	5/16/2022	130	0.0%	180,790	3/31/2022
2021 Q4	2/14/2022	409	0.0%	180,790	12/31/2021
2021 Q3	11/15/2021	502	0.0%	174,173	9/30/2021
2021 Q2	8/16/2021	753	0.0%	198,740	6/30/2021
2021 Q1	5/14/2021	316	0.0%	93,418	3/31/2021
2020 Q4	3/1/2021	247	0.0%	88,080	12/31/2020
2020 Q3	11/13/2020	221	0.0%	88,080	9/30/2020
2020 Q2	8/14/2020	1,211	0.0%	89,187	6/30/2020
2020 Q1	5/15/2020	600	0.0%	79,129	3/31/2020
2019 Q4	2/14/2020	528	0.0%	83,479	12/31/2019